| Literature DB >> 4027871 |
S McIntosh, M Chen, P A Sartain, C Duncan, R Fishburn, E H Klatskin, A D Schwartz, J L Venes.
Abstract
The use of adjuvant chemotherapy for cerebellar medulloblastoma is controversial. Twenty-one children and adolescents were treated with adjuvant low-dose cyclophosphamide and vincristine following surgery and radiotherapy. With a mean observation period of 6 years, the disease-free survival is 81%.Entities:
Mesh:
Substances:
Year: 1985 PMID: 4027871 DOI: 10.1002/1097-0142(19850915)56:6<1316::aid-cncr2820560616>3.0.co;2-d
Source DB: PubMed Journal: Cancer ISSN: 0008-543X Impact factor: 6.860